Auto-Injector Market Research Report Information By Product Type (Disposable, Reusable), Application (Anaphylaxis, Multiple Sclerosis, Diabetes, Allergies, Rheumatoid Arthritis, Others), Distribution Channel (Online Retailer, Pharmacy, Others), End-User (Home Care Settings, Hospitals & Clinics, Ambulatory Surgical Centers), and Region (Americas, Europe, Asia-Pacific, and Middle East and Africa)- Forecast till 2032

Table of Contents:

Chapter 1. Executive Summary

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.2.1 R&D and Designing

5.2.2 Manufacturing

5.2.3 Distribution & Sales

5.2.4 Post-Sales Review

Chapter 6. Global Auto-Injectors Market, by Product Type

6.1 Overview

6.2 Disposable

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Reusable

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Auto-Injectors Market, by Application

8.1 Overview

8.2 Anaphylaxis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Multiple Sclerosis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Diabetes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Allergies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.6 Rheumatoid Arthritis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Auto-Injectors Market, by Distribution Channel

8.1 Overview

8.2 Online Retailer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Pharmacy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Auto-Injectors Market, by End User

10.1 Overview

10.2 Home Care Settings

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

10.3 Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

10.4 Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 11. Global Auto-Injectors Market, by Region

11.1 Overview

11.2 Americas

11.2.1 North America

11.2.1.1 US

11.2.1.2 Canada

11.2.2 Latin America

11.3 Europe

11.3.1 Western Europe

11.3.1.1 Germany

11.3.1.2 France

11.3.1.3 Italy

11.3.1.4 Spain

11.3.1.5 UK

11.3.1.6 Rest of Western Europe

11.3.2 Eastern Europe

11.4 Asia-Pacific

11.4.1 Japan

11.4.2 China

11.4.3 India

11.4.4 Australia

11.4.5 South Korea

11.4.6 Rest of Asia-Pacific

11.5 Middle East & Africa

11.5.1 Middle East

11.5.2 Africa

Chapter 12. Company Landscape

12.1 Overview

12.2 Competitive Analysis

Chapter 13. Company Profile

13.1 Bayer AG

13.1.1 Company Overview

13.1.2 Products/Services Offered

13.1.3 Financial Overview

13.1.4 Key Developments

13.1.5 SWOT Analysis

13.1.6 Key Strategies

13.2 Haselmeier

13.2.1 Company Overview

13.2.2 Products/Services Offered

13.2.3 Financial Overview

13.2.4 Key Developments

13.2.5 SWOT Analysis

13.2.6 Key Strategies

13.3 Novartis AG

13.3.1 Company Overview

13.3.2 Products/Services Offered

13.3.3 Financial Overview

13.3.4 Key Development

13.3.5 SWOT Analysis

13.3.6 Key Strategies

13.4 Owen Mumford Ltd

13.4.1 Company Overview

13.4.2 Products/Services Offered

13.4.3 Financial Overview

13.4.4 Key Development

13.4.5 SWOT Analysis

13.4.6 Key Strategies

13.5 Becton, Dickinson and Company

13.5.1 Company Overview

13.5.2 Products/Services Offered

13.5.3 Financial overview

13.5.4 Key Developments

13.5.5 SWOT Analysis

13.5.6 Key Strategies

13.6 AbbVie Inc.

13.6.1 Company Overview

13.6.2 Products/Services Offered

13.6.3 Financial Overview

13.6.4 Key Developments

13.6.5 SWOT Analysis

13.6.6 Key Strategies

13.7 Johnson & Johnson

13.7.1 Overview

13.7.2 Products/Services Offered

13.7.3 Financial Overview

13.7.4 Key Developments

13.7.5 SWOT Analysis

13.7.6 Key Strategies

13.8 Amgen Inc.

13.8.1 Overview

13.8.2 Products/Services Offered

13.8.3 Financial Overview

13.8.4 Key Developments

13.8.5 SWOT Analysis

13.8.6 Key Strategies

13.9 Teva Pharmaceuticals USA

13.9.1 Overview

13.9.2 Products/Services Offered

13.9.3 Financial Overview

13.9.4 Key Developments

13.9.5 SWOT Analysis

13.9.6 Key Strategies

13.10 Biogen

13.10.1 Overview

13.10.2 Products/Services Offered

13.10.3 Financial Overview

13.10.4 Key Developments

13.10.5 SWOT Analysis

13.10.6 Key Strategies

13.11 Eli Lilly and Company

13.11.1 Overview

13.11.2 Products/Services Offered

13.11.3 Financial Overview

13.11.4 Key Developments

13.11.5 SWOT Analysis

13.11.6 Key Strategies

13.12 Mylan N.V.

13.12.1 Overview

13.12.2 Products/Services Offered

13.12.3 Financial Overview

13.12.4 Key Developments

13.12.5 SWOT Analysis

13.12.6 Key Strategies

13.13 Ypsomed AG

13.13.1 Overview

13.13.2 Products/Services Offered

13.13.3 Financial Overview

13.13.4 Key Developments

13.13.5 SWOT Analysis

13.13.6 Key Strategies

13.14 Merck KGaA

13.14.1 Overview

13.14.2 Products/Services Offered

13.14.3 Financial Overview

13.14.4 Key Developments

13.14.5 SWOT Analysis

13.14.6 Key Strategies

13.15 AstraZeneca

13.15.1 Overview

13.15.2 Products/Services Offered

13.15.3 Financial Overview

13.15.4 Key Developments

13.15.5 SWOT Analysis

13.15.6 Key Strategies

13.16 kaleo, Inc.

13.16.1 Overview

13.16.2 Products/Services Offered

13.16.3 Financial Overview

13.16.4 Key Developments

13.16.5 SWOT Analysis

13.16.6 Key Strategies

13.13 Others

Chapter 14 Appendix

14.1 References

14.2 Related Reports

LIST OF TABLES

Table 1 Global Auto-Injectors Market Synopsis, 2020-2027

Table 2 Global Auto-Injectors Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

Table 4 Global Auto-Injectors Market, by Application, 2020-2027 (USD Million)

Table 5 Global Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

Table 6 Global Auto-Injectors Market, by End User, 2020-2027 (USD Million)

Table 7 Global Auto-Injectors Market, by Region, 2020-2027 (USD Million)

Table 8 Americas: Auto-Injectors Market, by Region, 2020 and 2025

Table 9 Americas: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

Table 10 Americas: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

Table 11 Americas: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

Table 12 Americas: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

Table 13 North America: Auto-Injectors Market, by Country, 2020-2027 (USD Million)

Table 14 North America: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

Table 15 North America: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

Table 16 North America: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

Table 17 North America: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

Table 18 US: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

Table 19 US: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

Table 20 US: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

Table 21 US: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

Table 22 Canada: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

Table 23 Canada: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

Table 24 Canada: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

Table 25 Canada: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

Table 26 Latin America: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

Table 27 Latin America: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

Table 28 Latin America: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

Table 29 Latin America: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

Table 30 Europe: Auto-Injectors Market, by Region, 2020-2027 (USD Million)

Table 31 Europe: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

Table 32 Europe: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

Table 33 Europe: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

Table 34 Europe: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

Table 35 Western Europe: Auto-Injectors Market, by Country, 2020-2027 (USD Million)

Table 36 Western Europe: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

Table 37 Western Europe: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

Table 38 Western Europe: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

Table 39 Western Europe: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

Table 40 Eastern Europe: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

Table 41 Eastern Europe: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

Table 42 Eastern Europe: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

Table 43 Eastern Europe: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

Table 44 Asia-Pacific: Auto-Injectors Market, by Country, 2020-2027 (USD Million)

Table 45 Asia-Pacific: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

Table 46 Asia-Pacific: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

Table 47 Asia-Pacific: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

Table 48 Asia-Pacific: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

Table 49 Middle East & Africa: Auto-Injectors Market, by Region, 2020-2027 (USD Million)

Table 50 Middle East & Africa: Auto-Injectors Market, by Product Type, 2020-2027 (USD Million)

Table 51 Middle East & Africa: Auto-Injectors Market, by Application, 2020-2027 (USD Million)

Table 52 Middle East & Africa: Auto-Injectors Market, by Distribution Channel, 2020-2027 (USD Million)

Table 53 Middle East & Africa: Auto-Injectors Market, by End User, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure for Global Auto-Injectors Market

Figure 3 Market Dynamics for Global Auto-Injectors Market

Figure 4 Global Auto-Injectors Market Share, by Product Type, 2020 (%)

Figure 5 Global Auto-Injectors Market Share, by Product Type, 2020 (USD Million)

Figure 6 Global Auto-Injectors Market Share, by Application, 2020 (%)

Figure 7 Global Auto-Injectors Market Share, by Application, 2020 (USD Million)

Figure 8 Global Auto-Injectors Market Share, by Distribution Channel, 2020 (%)

Figure 9 Global Auto-Injectors Market Share, by Distribution Channel, 2020 (USD Million)

Figure 10 Global Auto-Injectors Market Share, by End User, 2020 (%)

Figure 11 Global Auto-Injectors Market Share, by End User, 2020 (USD Million)

Figure 12 Global Auto-Injectors Market Share, by Region, 2020 (%)

Figure 13 Americas: Auto-Injectors Market Share, by Region, 2020 (%)

Figure 14 North America: Auto-Injectors Market Share, by Country, 2020 (%)

Figure 15 Europe: Auto-Injectors Market Share, by Region, 2020 (%)

Figure 16 Western Europe: Auto-Injectors Market Share, by Country, 2020 (%)

Figure 17 Asia-Pacific: Auto-Injectors Market Share, by Country, 2020 (%)

Figure 18 Middle East & Africa: Auto-Injectors Market Share, by Region, 2020 (%)

Figure 19 Global Auto-Injectors Market: Company Share Analysis, 2020 (%)

Figure 20 Bayer AG: Key Financials

Figure 21 Bayer AG: Segmental Revenue

Figure 22 Bayer AG: Geographical Revenue

Figure 23 Haselmeier: Key Financials

Figure 24 Haselmeier: Segmental Revenue

Figure 25 Haselmeier: Geographical Revenue

Figure 26 Novartis AG: Key Financials

Figure 27 Novartis AG: Segmental Revenue

Figure 28 Novartis AG: Geographical Revenue

Figure 29 Owen Mumford Ltd: Key Financials

Figure 30 Owen Mumford Ltd: Segmental Revenue

Figure 31 Owen Mumford Ltd: Geographical Revenue

Figure 32 Becton, Dickinson and Company: Key Financials

Figure 33 Becton, Dickinson and Company: Segmental Revenue

Figure 34 Becton, Dickinson and Company: Geographical Revenue

Figure 35 AbbVie Inc.: Key Financials

Figure 36 AbbVie Inc.: Segmental Revenue

Figure 37 AbbVie Inc.: Geographical Revenue

Figure 38 Johnson & Johnson: Key Financials

Figure 39 Johnson & Johnson: Segmental Revenue

Figure 40 Johnson & Johnson: Geographical Revenue

Figure 41 Amgen Inc.: Key Financials

Figure 42 Amgen Inc.: Segmental Revenue

Figure 43 Amgen Inc.: Geographical Revenue

Figure 44 Teva Pharmaceuticals USA: Key Financials

Figure 45 Teva Pharmaceuticals USA: Segmental Revenue

Figure 46 Teva Pharmaceuticals USA: Geographical Revenue

Figure 47 Biogen: Key Financials

Figure 48 Biogen: Segmental Revenue

Figure 49 Biogen: Geographical Revenue

Figure 50 Eli Lilly and Company: Key Financials

Figure 51 Eli Lilly and Company: Segmental Revenue

Figure 52 Eli Lilly and Company: Geographical Revenue

Figure 53 Mylan NV: Key Financials

Figure 54 Mylan NV: Segmental Revenue

Figure 55 Mylan NV: Geographical Revenue

Figure 56 Ypsomed AG: Key Financials

Figure 57 Ypsomed AG: Segmental Revenue

Figure 58 Ypsomed AG: Geographical Revenue

Figure 59 Merck KGaA: Key Financials

Figure 60 Merck KGaA: Segmental Revenue

Figure 61 Merck KGaA: Geographical Revenue

Figure 62 AstraZeneca: Key Financials

Figure 63 AstraZeneca: Segmental Revenue

Figure 64 AstraZeneca: Geographical Revenue

Figure 65 kaleo, Inc.: Key Financials

Figure 66 kaleo, Inc.: Segmental Revenue

Figure 67 kaleo, Inc.: Geographical Revenue